Premium
Progression‐free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint?
Author(s) -
Becker Andreas,
Eichelberg Christian,
Sun Maxine
Publication year - 2013
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28378
Subject(s) - surrogate endpoint , medicine , clinical endpoint , progression free survival , endpoint determination , clinical trial , overall survival , survival analysis , intensive care medicine , oncology
In this editorial, the authors critically discuss the current role and limitations of progression‐free survival as a surrogate endpoint of overall survival in clinical trials.